53863 Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 clinical trials of adults and children with atopic dermatitis

Autor: Simpson, Eric, Boguniewicz, Mark, Eichenfield, Lawrence, Gonzales, Mercedes E., Hebert, Adelaide A., Prajapati, Vimal H., Gooderham, Melinda, Krupa, David, Chu, David H., Higham, Robert C., Berk, David R.
Zdroj: In Journal of the American Academy of Dermatology September 2024 91(3) Supplement:AB281-AB281
Databáze: ScienceDirect